ÂÜÀòÂÒÂ×

The Leadership Team at GI Dynamics is responsible for strategic decision-making and overseeing the company's direction in developing innovative therapies for type 2 diabetes and related metabolic diseases. This team, comprising the President & CEO, VP of Clinical, Regulatory & Quality, and VP of Regulatory Affairs/Clinical Affairs, ensures compliance with industry regulations, drives clinical research initiatives, and guides overall business strategy to enhance patient outcomes and achieve corporate goals.